Xenglu-Met [Empagliflozin+Metformin HCL] 5mg+850mg 14 tablets

Xenglu-Met (Empagliflozin 5mg + Metformin HCL 850mg) Tablets

Dual-Action Therapy for Type 2 Diabetes Management

Xenglu-Met is a combination of Empagliflozin (SGLT2 inhibitor) and Metformin HCL (biguanide), designed to provide effective blood sugar control for adults with Type 2 diabetes. This dual-action medication helps lower glucose absorption, increase glucose excretion through urine, and improve insulin sensitivity, leading to better diabetes management and potential weight loss benefits.

Key Benefits

✔ Effectively Lowers Blood Sugar – Helps maintain stable glucose levels.
✔ Aids in Weight Loss – Promotes glucose excretion, reducing fat accumulation.
✔ Improves Insulin Sensitivity – Helps the body utilize insulin more effectively.
✔ Supports Heart & Kidney Health – Reduces risks of cardiovascular and renal complications.
✔ Dual-Mechanism for Enhanced Control – Combines two proven diabetes treatments for better results.

How to Use

• Take one tablet daily, or as prescribed by your doctor.
• Swallow whole with water; do not crush or chew.
• Best taken with meals to minimize stomach discomfort.
• Follow your doctor’s dietary and exercise guidelines for optimal results.

Important Information

• Drink plenty of water to prevent dehydration due to increased urination.
• Monitor kidney function regularly, as Empagliflozin impacts kidney performance.
• Possible mild urinary or genital infections due to increased sugar in urine.
• Not suitable for patients with Type 1 diabetes or severe kidney disease.
• Consult a doctor before use if pregnant or breastfeeding.

Xenglu-Met is a highly effective treatment for Type 2 diabetes, helping patients achieve better blood sugar control, support weight management, and reduce the risk of complications.